Hangzhou AGS MedTech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	541.91	588.02	632.86	506.09	368.92	305.1
Other Revenue	5.72	5.72	3.78	2.65	2.2	0.37
Revenue	547.63	593.74	636.63	508.75	371.11	305.47
Revenue Growth	-18.11%	-6.74%	25.14%	37.09%	21.49%	77.64%
Cost of Revenue	159.06	173.94	180.84	149.86	119.38	108.54
Gross Profit	388.58	419.8	455.79	358.89	251.73	196.92
Selling, General & Admin	123.43	124.4	108.89	95.38	66.59	53
Research & Development	74.97	75.89	59.21	41.25	31.46	24.19
Other Operating Expenses	17.26	8.55	6.09	1.39	3.29	2.43
Operating Expenses	215.12	209.13	173.69	140.17	101.63	79.83
Operating Income	173.45	210.68	282.11	218.72	150.1	117.09
Interest Expense	-	-0.11	-0.05	-	-	-
Interest & Investment Income	56.31	45.76	55.23	28.91	2.59	2.52
Currency Exchange Gain (Loss)	-6.03	-6.03	0.32	0.69	11.1	-4.24
Other Non Operating Income (Expenses)	-1.73	-0.4	1.24	-1.05	-0.84	-0.14
EBT Excluding Unusual Items	202.88	249.91	338.85	247.28	162.95	115.23
Gain (Loss) on Sale of Investments	6.83	2.51	2.08	0.41	-7.19	1.09
Gain (Loss) on Sale of Assets	-0.56	-0.3	-0.2	-0.8	-0.14	-0.01
Asset Writedown	-4.27	-	-	-	-0	-0.14
Other Unusual Items	15.79	9.93	2.87	4.78	9.94	3.79
Pretax Income	220.67	262.05	343.6	251.67	165.56	119.97
Income Tax Expense	33.65	40.61	50.21	34.43	20.6	15.17
Earnings From Continuing Operations	187.03	221.44	293.39	217.24	144.96	104.8
Minority Interest in Earnings	0.81	0.28	-	-	-	-
Net Income	187.84	221.71	293.39	217.24	144.96	104.8
Net Income to Common	187.84	221.71	293.39	217.24	144.96	104.8
Net Income Growth	-31.18%	-24.43%	35.06%	49.86%	38.32%	131.68%
Shares Outstanding (Basic)	80	80	81	73	61	61
Shares Outstanding (Diluted)	80	80	81	73	61	61
Shares Change	-0.92%	-0.13%	11.02%	19.46%	-	-
EPS (Basic)	2.34	2.76	3.64	2.99	2.39	1.72
EPS (Diluted)	2.34	2.75	3.64	2.99	2.39	1.72
EPS Growth	-30.55%	-24.33%	21.65%	25.44%	38.60%	131.71%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	145.54	87.74	266.19	169.88	96.26	102.59
Free Cash Flow Per Share	1.81	1.09	3.30	2.34	1.58	1.69
Dividend Per Share	1.039	1.039	1.373	1.036	0.543	-
Dividend Growth	-24.35%	-24.35%	32.62%	90.77%	-	-
Gross Margin	70.95%	70.70%	71.59%	70.54%	67.83%	64.47%
Operating Margin	31.67%	35.48%	44.31%	42.99%	40.45%	38.33%
Profit Margin	34.30%	37.34%	46.09%	42.70%	39.06%	34.31%
Free Cash Flow Margin	26.58%	14.78%	41.81%	33.39%	25.94%	33.59%
EBITDA	187.41	222.59	291.28	225.29	154.82	121.17
EBITDA Margin	34.22%	37.49%	45.75%	44.28%	41.72%	39.67%
D&A For EBITDA	13.96	11.91	9.17	6.56	4.72	4.07
EBIT	173.45	210.68	282.11	218.72	150.1	117.09
EBIT Margin	31.67%	35.48%	44.31%	42.99%	40.45%	38.33%
Effective Tax Rate	15.25%	15.50%	14.61%	13.68%	12.44%	12.64%
Revenue as Reported	134.42	593.74	636.63	508.75	371.11	-